Jamp-Metformin Product Recall (2020-03-10)

Starting date:
March 10, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-72565

Last updated:

Summary

  • Product: A. Jamp-Metformin 500 mg tablet    B. Jamp-Metformin 850 mg tablet

A. Jamp-Metformin 500 mg tablet  

B. Jamp-Metformin 850 mg tablet

Reason

Affected lots may contain N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit.

Depth of distribution

Retailers

Affected products

A. Jamp-Metformin 500 mg tablet

DIN, NPN, DIN-HIM

DIN 02380196

Dosage form

tablet

Strength

Metformin hydrochloride 500 mg

Lot or serial number

X20283, X20284, X20286, X20287, X20288, Y00225, Y00226, Y00227, Y00228, Y00229, Y00230, Y00231, Y00232, Y01573, Y01574, Y01575, Y01576, Y01577, Y01578, Y01579, Y01580

Companies

Recalling Firm
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
Marketing Authorization Holder
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA

B. Jamp-Metformin 850 mg tablet

DIN, NPN, DIN-HIM

DIN 02380218

Dosage form

tablet

Strength

Metformin hydrochloride 850 mg

Lot or serial number

X20385, X20386, X19224, X19225, X19226

Companies

Recalling Firm
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
Marketing Authorization Holder
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA